Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/idempotent annotations, the description discloses substantial behavior: fan-out across multiple data sources, USPTO sunset soft-fail behavior, empty fda_products being expected rather than an error, sources_used/sources_failed semantics, and name-resolution behavior including resolved_from/resolved_to. No contradiction with annotations exists.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and front-loaded with usage triggers and the ALWAYS PREFER directive. While lengthy, most sentences earn their place given the tool's complexity, though a single long run-on block with minimal formatting slightly hurts scannability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description enumerates all major return sections (recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI) and clarifies failure semantics for empty sections. Exact nested field shapes are not fully specified, but the description is sufficient for correct tool selection and invocation.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description enriches parameter understanding by explaining that type 'company' and 'ticker' are interchangeable, that value can be a ticker, zero-padded CIK, or company name, and that names resolve via SEC EDGAR. This adds practical nuance beyond the schema fields.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly identifies entity_profile as a full cross-source profile tool for US public companies, anchored by concrete trigger phrases like 'Tell me about X' and 'brief me on Tesla'. It differentiates itself from generic research siblings by emphasizing 'ONE parallel call' and 'ALWAYS PREFER' over chaining single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly states when to use: 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also defines accepted input forms (ticker, CIK, company name) and documents the edge case where a private company returns resolved:false with a notes line rather than a bare failure.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Many tools have overlapping purposes, e.g., ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and validate_claim all route queries to the same data sources with only subtle differences. Similarly, bet_research, polymarket_edges, polymarket_arbitrage, and polymarket_edge_tracker all analyze prediction markets, making it hard for an agent to pick the right one without deep reading of descriptions.

Naming Consistency3/5

Tool names follow a mix of patterns: some are verb_noun (generate_llms_txt, list_subscriptions), some noun_verb (ai_visibility_check, bet_research), and some are just nouns (datasets, metadata). The ask_pipeworx family has consistent prefixes but suffixes vary. Overall readable but inconsistent.

Tool Count2/5

34 tools is excessive for a coherent server. The server tries to be a Swiss Army knife covering data lookup, prediction markets, Delaware open data, memory, subscriptions, and misc tools like generate_llms_txt and scan_dependency. Many tools feel tacked on, and the count makes it unwieldy for an agent to navigate.

Completeness3/5

The server covers multiple domains thoroughly (data query via Pipeworx variants, prediction markets with arbitrage and edges, Delaware open data, memory, subscriptions). However, there are gaps: no tool for managing custom pipelines or for updating data. For the broad scope, it is decent but not fully comprehensive.